Does Dr. ISSA ALESH have financial conflicts of interest?

Dr. ISSA ALESH (M.D.) has received a total of $3,411 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $3,411 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ISSA ALESH?

According to CMS Open Payments data, Dr. ISSA ALESH received funding from NOVARTIS PHARMACEUTICALS CORPORATION ($681), MERCK SHARP & DOHME ($477), and AMGEN ($301).

Does Dr. ISSA ALESH receive research grants or speaking fees?

Dr. ISSA ALESH has received $3,411 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ISSA ALESH

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: SAN BERNARDINO, CA 92404

NPI Number: 1750319778

LIFETIME INDUSTRY VALUE

$3,411

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ALESH is a verified Internal Medicine, Cardiovascular Disease practitioner based in SAN BERNARDINO, CA.

Between 2021 and 2024, Dr. ALESH had an overall industry promotional and research financial footprint of $3,411 as recorded in the federal CMS Open Payments database.

$3,411 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALESH's primary funding source is NOVARTIS PHARMACEUTICALS CORPORATION, which accounts for $681 (representing 20% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 1

$681

20%

MERCK SHARP & DOHME

Rank 2

$477

14%

AMGEN

Rank 3

$301

8.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.